Pfizer Shares Close Down 2.38% Friday

Wall St. Watchdog reveals information on today’s market action by the top stocks, as measured by market capitalization, in the Healthcare sector:

  1. Pfizer Inc. (NYSE:PFE): The shares closed at $18.46, down $0.45, or 2.38%, on the day. They have traded in a 52-week range of $16.21 to $21.45. Volume today was 34,637,111 shares, against a 3-month average volume of 50,950,900 shares. Its market capitalization is $144.03billion, its trailing P/E is 17.24, its trailing earnings are $1.07 per share, and it pays a dividend of $0.80 per share, for a dividend yield of 4.20%. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  2. Novartis AG (ADR) (NYSE:NVS): The shares closed at $57.30, down $1.27, or 2.17%, on the day. They have traded in a 52-week range of $52.09 to $64.82. Volume today was 1,567,165 shares, against a 3-month average volume of 2,913,330 shares. Its market capitalization is $139.04billion, its trailing P/E is 13.52, its trailing earnings are $4.24 per share, and it pays a dividend of $2.00 per share, for a dividend yield of 3.40%. About the company: Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases; oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis; vaccines and diagnostics; vision, and animal health products.
  3. GlaxoSmithKline plc (ADR) (NYSE:GSK): The shares closed at $41.74, down $0.87, or 2.04%, on the day. They have traded in a 52-week range of $36.28 to $45.34. Volume today was 3,040,579 shares, against a 3-month average volume of 2,908,540 shares. Its market capitalization is $106.65billion, its trailing P/E is 20.40, its trailing earnings are $2.05 per share, and it pays a dividend of $2.08 per share, for a dividend yield of 4.90%. About the company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
  4. Merck & Co., Inc. (NYSE:MRK): The shares closed at $32.37, down $0.53, or 1.61%, on the day. They have traded in a 52-week range of $29.47 to $37.68. Volume today was 13,201,576 shares, against a 3-month average volume of 15,514,300 shares. Its market capitalization is $99.73billion, its trailing P/E is 34.88, its trailing earnings are $0.93 per share, and it pays a dividend of $1.52 per share, for a dividend yield of 4.60%. About the company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  5. Sanofi SA (ADR) (NYSE:SNY): The shares closed at $35.05, down $1.29, or 3.55%, on the day. They have traded in a 52-week range of $29.66 to $40.75. Volume today was 3,745,672 shares, against a 3-month average volume of 4,155,390 shares. Its market capitalization is $94.09billion, its trailing P/E is 14.96, its trailing earnings are $2.34 per share, and it pays a dividend of $1.32 per share, for a dividend yield of 3.60%. About the company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
  6. Abbott Laboratories (NYSE:ABT): The shares closed at $51.04, down $0.9, or 1.73%, on the day. They have traded in a 52-week range of $45.07 to $54.24. Volume today was 5,163,367 shares, against a 3-month average volume of 7,659,830 shares. Its market capitalization is $79.45billion, its trailing P/E is 15.56, its trailing earnings are $3.28 per share, and it pays a dividend of $1.92 per share, for a dividend yield of 3.70%. About the company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  7. AstraZeneca plc (ADR) (NYSE:AZN): The shares closed at $45.08, down $1.61, or 3.45%, on the day. They have traded in a 52-week range of $40.89 to $53.50. Volume today was 1,950,412 shares, against a 3-month average volume of 1,854,430 shares. Its market capitalization is $61.58billion, its trailing P/E is 7.80, its trailing earnings are $5.78 per share, and it pays a dividend of $1.70 per share, for a dividend yield of 3.60%. About the company: AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and sells pharmaceutical and medical products. The Group focuses its operations on seven therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia and Infection.
  8. Novo Nordisk A/S (ADR) (NYSE:NVO): The shares closed at $103.89, down $2.79, or 2.62%, on the day. They have traded in a 52-week range of $87.18 to $132.88. Volume today was 212,209 shares, against a 3-month average volume of 338,377 shares. Its market capitalization is $59.12billion, its trailing P/E is 19.75, its trailing earnings are $5.26 per share, and it pays a dividend of $1.36 per share, for a dividend yield of 1.30%. About the company: Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
  9. Amgen, Inc. (NASDAQ:AMGN): The shares closed at $54.10, down $0.92, or 1.67%, on the day. They have traded in a 52-week range of $47.66 to $61.53. Volume today was 6,161,827 shares, against a 3-month average volume of 6,570,000 shares. Its market capitalization is $49.99 billion, its trailing P/E is 11.25, its trailing earnings are $4.81 per share, and it pays a dividend of $1.12 per share, for a dividend yield of 2.00%. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  10. Johnson & Johnson (NYSE:JNJ): The shares closed at $64.07, down $1.26, or 1.93%, on the day. They have traded in a 52-week range of $57.50 to $68.05. Volume today was 13,546,001 shares, against a 3-month average volume of 14,197,200 shares. Its market capitalization is $175.57billion, its trailing P/E is 15.33, its trailing earnings are $4.18 per share, and it pays a dividend of $2.28 per share, for a dividend yield of 3.50%. About the company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>